The Latest Cardiac and Vascular News
DUBLIN–(BUSINESS WIRE)–The “North America Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Electrocardiograph (ECG) Market is expected to witness market growth of 4.9% CAGR during the forecast period (2017 – 2023). Electrocardiography (ECG) is a non-invasive medical test used in recording electrical activity of the heartbeat over […]
DUBLIN–(BUSINESS WIRE)–The “North America Vascular Graft Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Vascular Graft Market is expected to witness market growth of 5.4% CAGR during the forecast period (2017 – 2023). A vascular graft is a medical device which is used as an artificial blood vessel. These […]
DUBLIN–(BUSINESS WIRE)–The “Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. “Global TAVI Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S and European markets. The global TAVI market is expected to grow in future due […]
IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]
AMSTERDAM, March 23, 2018 /CNW/ – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology has delivered a broad range of health technology solutions to the University of Ottawa Heart Institute (UOHI) – Canada’s largest and foremost heart health centre dedicated to understanding, treating, and preventing heart disease. Today, […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has announced the first patient enrollment in the Perceval® Valve Clinical study for Chinese Registration (“PERFECT”) Trial. The study is a pre-market, prospective, single-arm trial. The PERFECT trial is being conducted to demonstrate the safety and effectiveness of […]
IRVINE, Calif., March 21, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that enrollment is complete in the computed tomography (CT) imaging sub-study within the PARTNER 3 trial of the SAPIEN 3 valve. This randomized sub-study is examining […]
ALAMEDA, Calif., March 21, 2018 /PRNewswire/ — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singulex cTnI assay and Single Molecule Counting technology can independently predict moderate and severe coronary disease (CAD), suggesting its clinical utility for accurate, safe and cost-effective evaluation of patients in an outpatient setting, […]
DURHAM, N.C., March 20, 2018 /PRNewswire/ — Micell® Technologies, Inc., a privately-held, development-stage biomedical company, today provided an update on its recently expanded intellectual property portfolio. With the granting of 24 patents in 2017, including eight that issued in the fourth quarter, Micell’s extensive intellectual property portfolio comprises 186 patents (166 issued […]
ABBOTT PARK, Ill., March 19, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced that the Ministry of Health Labour and Welfare (MHLW) in Japan granted national reimbursement for the company’s MitraClip therapy to treat people with mitral regurgitation, a serious, progressive heart disease in which the mitral valve does not close properly, […]
